Development of a Partial Proteolysis Targeting Chimera Library Based on Achiral Cereblon E3 Ligase Ligands and its Application for Bruton's Tyrosine Kinase Degraders. [PDF]
ChemMedChemAlmodóvar-Rivera CM +5 more
europepmc +1 more source
Zanubrutinib-based regimen as the salvage or bridging treatment of CART therapy in relapsed or refractory, non-germinal center B-cell-like diffuse large B-cell lymphoma: a retrospective multicenter cohort study. [PDF]
Front ImmunolLu Y +6 more
europepmc +1 more source
X-linked Agammaglobulinemia First Diagnosed in Adulthood with Recurrent Pneumonia and Multiple Warty Skin Nodules. [PDF]
Intern MedIsawa M +13 more
europepmc +1 more source
Human resistin is critical to activation of the NLRP3 inflammasome in macrophages. [PDF]
PLoS OneKariyawasam U +7 more
europepmc +1 more source
Case Report: Preserved umbilical cords underscore family histories of inborn errors of immunity. [PDF]
Front ImmunolNishimura M +4 more
europepmc +1 more source
Discovery of Covalent Ligands with AlphaFold3. [PDF]
J Am Chem SocShamir Y +5 more
europepmc +1 more source
Exploratory Covalent Docking of Michael-Acceptor Natural Products at Reactive Cysteines in Cancer Tyrosine Kinases. [PDF]
Int J Mol SciLobo F +5 more
europepmc +1 more source
Real-world treatment patterns of Bruton tyrosine kinase inhibitors in mantle cell lymphoma in a community oncology setting. [PDF]
Future OncolShah BD, Xue M, Furnback W, Yang K.
europepmc +1 more source
Effects of Btk-inhibitors with varying selectivity and reversibility on platelet aggregation [PDF]
, 2022 Duan, Rundan
core